Stay updated on CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays the site revision as v3.5.2, replacing v3.5.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check36 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedA new site revision tag v3.4.2 was added, and the funding status notice along with the previous revision v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check72 days agoChange DetectedA government funding notice about operation status was added. The site revision was updated to v3.4.1, and the previous revision v3.4.0 was removed.SummaryDifference0.5%

- Check79 days agoChange DetectedThe update adds a glossary display option and makes small metadata/text changes (revision version and capitalization) without affecting study content, endpoints, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page.